CIENTIFIC MSDS #: 658.00 Material Safety Data Sheet (MSDS) Revision Date: SECTION 1 — CHEMICAL PRODUCT AND COMPANY IDENTIFICATION Progesterone
Flinn Scientific, Inc. P.O. Box 219 Batavia, IL 60510 (800) 452-1261
CHEMTREC Emergency Phone Number: (800) 424-9300
SECTION 2 — COMPOSITION, INFORMATION ON INGREDIENTS
ProgesteroneSynonym: Pregn-4-ene-3,20-dione
SECTION 3 — HAZARDS IDENTIFICATION LINN AT-A-GLANCE
Possible human carcinogen (IARC-2B). Body tissue irritant. Moderately toxic by ingestion and
inhalation. Avoid all body contact. Not for human use.
Flammability-0Reactivity-0Exposure-2Storage-0
SECTION 4 — FIRST AID MEASURES
Call a physician and seek medical attention for further treatment, observation, and support after first aid. Inhalation: Remove to fresh air at once. If breathing has stopped, give artificial respiration immediately. Eye or External: Immediately flush with fresh water for at least 15 minutes. Internal: Rinse mouth. Give large quantities of water for dilution. Call a physician or poison control at once. SECTION 5 — FIRE FIGHTING MEASURES NFPA CODE SECTION 6 — ACCIDENTAL RELEASE MEASURES
Restrict unprotected personnel from area. Sweep up, place in sealed bag or container and dispose. Ventilate area and wash spill siteafter material pickup is complete. See Sections 8 and 13 for further information. SECTION 7 — HANDLING AND STORAGE
Flinn Suggested Chemical Storage Pattern: Organic #2. Store with alcohols, glycols, amines and amides. Use and dispense in a hood. Store in a cool dry place and protect from light. SECTION 8 — EXPOSURE CONTROLS, PERSONAL PROTECTION
Avoid contact with eyes, skin, and clothing. Wear chemical splash goggles, chemical-resistant gloves, and chemical-resistantapron.
2012 Flinn Scientific, Inc. All Rights Reserved. PAGE 1 OF 2 FLINN SCIENTIFIC, INC. Material Safety Data Sheet Progesterone MSDS #: 658.00 Revision Date: February 2, 2012 SECTION 9 — PHYSICAL AND CHEMICAL PROPERTIES
Solubility: Insoluble in water; soluble in alcohol, acetone
SECTION 10 — STABILITY AND REACTIVITY
Avoid contact with strong oxidizers. Shelf life: Indefinite, if stored properly. SECTION 11 — TOXICOLOGICAL INFORMATION
Chronic effects: Possible carcinogen, mutagen, jaundice
Target organs: Female/male reproductive system.
N.A. = Not available, not all health aspects of this substance have been fully investigated. SECTION 12 — ECOLOGICAL INFORMATION SECTION 13 — DISPOSAL CONSIDERATIONS
Please review all federal, state and local regulations that may apply, before proceeding. Flinn Suggested Disposal Method #26a is one option. SECTION 14 — TRANSPORT INFORMATION
Shipping name: Not regulatedHazard class: N/AUN number: N/AN/A = Not applicable
SECTION 15 — REGULATORY INFORMATION
TSCA-listed, EINECS-listed (200-350-6). SECTION 16 — OTHER INFORMATION This Material Safety Data Sheet (MSDS) is for guidance and is based upon information and tests believed to be reliable. Flinn Scientific, Inc. makes no guarantee of the accuracy or completeness of the data and shall not be liable for any damages relating thereto. The data is offered solely for your consideration, investigation, and verification. The data should not be confused with local, state, federal or insurance mandates, regulations, or requirements and CONSTITUTE NO WARRANTY. Any use of this data and information must be determined by the science instructor to be in accordance with applicable local, state or federal laws and regulations. The conditions or methods of handling, storage, use and disposal of the product(s) described are beyond the control of Flinn Scientific, Inc. and may be beyond our knowledge. FOR THIS AND OTHER REASONS, WE DO NOT ASSUME RESPONSIBILITY AND EXPRESSLY DISCLAIM LIABILITY FOR LOSS, DAMAGE OR EXPENSE ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE HANDLING, STORAGE, USE OR DISPOSAL OF THIS PRODUCT(S). Consult your copy of the Flinn Science Catalog/Reference Manual for additional information about laboratory chemicals.
2012 Flinn Scientific, Inc. All Rights Reserved. PAGE 2 OF 2
⅐ N U M B E R 3 1 ⅐ N O V E M B E R 1 2 0 0 9Preoperative Multimodality Therapy Improves Disease-FreeSurvival in Patients With Carcinoma of the Rectum:NSABP R-03 Mark S. Roh, Linda H. Colangelo, Michael J. O’Connell, Greg Yothers, Melvin Deutsch, Carmen J. Allegra,Morton S. Kahlenberg, Luis Baez-Diaz, Carol S. Ursiny, Nicholas J. Petrelli, and Norman Wolmark Purpose Although chemoradioth
¿Ha sido víctima de discriminación en servicios de vivienda? De acuerdo con la ley federal y estatal contra la discriminación, es ilegal discriminar en la venta o renta de viviendas o en los préstamos o seguros de viviendas por razones de: Condición familiar (familias con hijos menores de 18 años) Condición como veterano o miembro de las Fuerzas Armadas de Estados Unidos Co